Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4112
-0.0030 (-0.72%)
May 21, 2025, 12:50 PM - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $9.06 million as of May 21, 2025. Its market cap has decreased by -72.98% in one year.
Market Cap
9.06M
Enterprise Value
4.49M
1-Year Change
-72.98%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $9.06M, a decrease of -84.17%. That is a compound annual growth rate of -37.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 8.93M | -35.06% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.91B |
| Johnson & Johnson | 370.05B |
| AbbVie | 323.66B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 276.18B |
| Abbott Laboratories | 233.43B |
| Novartis AG | 219.90B |
| AstraZeneca | 215.95B |